Spry Health launches service using wearable Loop device to improve at-home patient monitoring during COVID-19 outbreak

Spry Health announced on Friday the US launch of Loop Signal, a new clinician-led COVID-19 monitoring service using the company’s FDA-cleared Loop system, a wrist-worn device that measures pulse oximetry, respiration rate and heart rate. The service aims to "reduce avoidable hospital visits and to improve at-home monitoring of patients confirmed, suspected, or at risk for COVID-19," Spry Health said.

CEO Pierre-Jean Cobut remarked that "many organisations are nearing their maximum capacity due to the large influx of patients showing up to emergency departments, often without meeting the necessary criteria for [COVID-19] testing" set by the US Centers for Disease Control and Prevention. With the new service, he said "clinicians can focus on the patients that need critical care, while we help monitor high-risk populations and intervene in advance of an emergency when early signs of deterioration are detected."

The Loop system was cleared by the FDA last April as a tool for clinicians to remotely monitor their patients with chronic diseases, such as chronic obstructive pulmonary disease, allowing them to detect early signs of deterioration. The system will ensure that healthcare teams can monitor patient vitals deemed critical to assess COVID-19 severity, Spry Health said, citing recent guidance from the World Health Organization. The device, whose clinical dashboard aggregates data to easily identify patients at risk and prioritise care, does not require any input or data from patients, nor does it require a smartphone or app.

With the service, medical providers can prescribe the Loop system to patients and enrol them into the monitoring programme either remotely, at point-of-care, or upon emergency department discharge. Patients with signs of deterioration are contacted by telephone and treated remotely when possible, Spry Health said.

Also on Friday, the FDA issued guidance aiming to increase remote monitoring device availability during the COVID-19 pandemic.

Did you like this article?